Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant…

Start of the Einstein Center for Early Disease Interception

In its December meeting, the Board of the Einstein Foundation Berlin approved new research projects with a total funding of 13 million euros over the next six years.

Deadline: 13th February 2026

ProBioGen announced today the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targeted therapies to induce central immune tolerance.

Surprisingly, unmodified mRNA does not trigger an inflammatory response in T cells

Deadline: Februrary 1st 2026

Karen Christman, a Stiftung Charité Visiting Fellow at the Max Delbrück Center, is among the first researchers to have won a Humboldt Research Award under Germany’s Global Minds Initiative. The award will enable her to expand her research in Germany…

The Max Delbrück Center has recently completed construction of a new Demonstrator Lab as a testbed to reduce the environmental impact of biomedical research. The insights gained will be applied to all new building renovations across the center.

A team of researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center has captured the fleeting moment a nerve cell releases its neurotransmitters into the synaptic cleft. Their microscopic images and description of the process…